FDA authorizes first pediatric COVID-19 vaccine; CDC to consider next week
![FDA-guidance](/sites/default/files/styles/900x400/public/2018-07/FDA-guidance.jpg?itok=I8jaZmAO)
The Food and Drug Administration today authorized Pfizer’s COVID-19 vaccine for pediatric use, moving the issue of administration to the Centers for Disease Control and Prevention for consideration. FDA’s authorization of the Pfizer vaccine, which is for children ages 5-11, heeds the recommendation of its independent advisory committee, made earlier this week. The CDC’s own independent advisers meet Nov. 2 to consider the available data, after which the agency’s director will need to formally sign off before the vaccine can be administered to that age group.
Related News Articles
Headline
The Centers for Disease Control and Prevention Aug. 13 issued an advisory alerting of an uptick of cases of parvovirus B19 across the U.S. Parvovirus B19 is a…
Headline
Adults age 65 and older are encouraged to receive an updated dosage of the COVID-19 vaccine, the Centers for Disease Control and Prevention announced April 25…
Headline
The Pfizer and Moderna COVID-19 vaccines can cause myocarditis, but do not appear to cause infertility, Guillain-Barré syndrome, Bell’s palsy, thrombosis with…
Headline
Centers for Disease Control and Prevention Director Mandy Cohen, M.D., Feb. 28 endorsed a recommendation by its Advisory Committee on Immunization Practices…
Headline
Paxlovid may no longer be distributed with an emergency use label after March 8, the Food and Drug Administration announced. Providers may dispense unexpired…
Headline
A CDC study released Dec. 21 found low COVID-19 and flu vaccination coverage for most adults, and low RSV vaccination coverage for adults aged 60 and…